Loading...
Health resource utilization for inpatients with COPD treated with nebulized arformoterol or nebulized formoterol
OBJECTIVE: Arformoterol is the (R,R)-enantiomer of formoterol. Preclinical studies suggest that it is a stronger bronchodilator than the racemic (R,R/S,S)-formoterol; however, its potential clinical advantages have not been demonstrated. This study compared the length of stay (LOS), 30-day readmissi...
Na minha lista:
| Udgivet i: | Int J Chron Obstruct Pulmon Dis |
|---|---|
| Main Authors: | , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Dove Medical Press
2017
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5490469/ https://ncbi.nlm.nih.gov/pubmed/28694692 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/COPD.S134145 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|